Funding Details
- Awarder
- Inbox
- Date Award
- April 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- Granite Bio has secured $100 million in funding, indicating strong investor confidence and market potential for its antibody treatments.
- Company Description
- Granite Bio is a Swiss-based immunology company focused on developing new antibody treatments targeting various autoimmune diseases. The company aims to address fundamental disease drivers at their source with innovative therapies.
- Market
- Immunology
- Location
-
Switzerland
- Coinvestors
- Versant Ventures, Novartis Venture Fund, Sanofi Ventures, Forbion
Links